Cita APA

Serna-Blasco, R., Mediavilla-Medel, P., Medinab, K., Sala, M., Aguiar, D., Díaz-Serrano, A., . . . Provencio, M. (2025). Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study.

Citación estilo Chicago

Serna-Blasco, R., et al. Comprehensive Molecular Profiling of Advanced NSCLC Using NGS: Prevalence of Druggable Mutations and Clinical Trial Opportunities in the ATLAS Study. 2025.

Cita MLA

Serna-Blasco, R., et al. Comprehensive Molecular Profiling of Advanced NSCLC Using NGS: Prevalence of Druggable Mutations and Clinical Trial Opportunities in the ATLAS Study. 2025.